First Bundibugyo Ebola vaccine trial begins as DRC death toll exceeds 1,300

Oxford dosed the first volunteer in the world's first Bundibugyo ebolavirus vaccine trial on July 24, 2026. The DRC outbreak — caused by Bundibugyo, which has no approved vaccines or treatments — has killed 1,309 people across 2,973 confirmed cases, a 40 percent rise in five days. A deployable vaccine remains months away.